January 12: Team Innovation Backs Odd Not Even; Karan Aujla Merch
Karan Aujla merch goes global as Team Innovation backs Odd Not Even. We break down growth drivers, risks, and what India’s investors should watch in 2026.
Karan Aujla merch goes global as Team Innovation backs Odd Not Even. We break down growth drivers, risks, and what India’s investors should watch in 2026.
Earnings preview and Meyka AI analysis of 2502.T stock ahead of 16 Jan 2026 results
8412.HK stock falls 17.78% to HK$0.37 on 12 Jan 2026; valuation, volume and Meyka AI forecast reviewed
SNH.DE stock trades at €0.159 intraday with heavy volume; our Meyka AI view and forecast outline upside and risks
Tohoku Shinkansen delay on Jan 12: JR East disruption up to 50 minutes between Tokyo and Sendai after points checks at Nasushiobara station amid snow. Investor takeaways on costs, ridership, and local
S51.SI stock jumps 10.87% to S$2.55 on 12 Jan 2026; volume 108,233,700. We analyse catalysts, metrics and Meyka forecast.
ALE.CN stock jumps 53.85% to C$0.10 on Jan 12 2026; volume surge and technicals show overbought but momentum
Biotech stocks often pause before big industry events. That is exactly what is happening with Mereo BioPharma. As of January 2026, Mereo BioPharma shares are trading in a narrow range, following weeks of sharp moves and heavy investor debate. The timing is not random. The global biotech spotlight is shifting toward the J.P. Morgan Healthcare…
AIM.AX stock closed A$0.79 on 12 Jan 2026. AIM.AX stock analysis, Meyka AI grade and A$1.01 12‑month forecast
Canada market watch: directed energy weapons headlines test risk appetite. What it means for ^NDX, sector rotation, and defense stocks amid rising geopolitical risk.